Here is the latest shareholding Pattern of VISTA PHARMA. For more details, see the VISTA PHARMA financial fact sheet and VISTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22 |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 2.04 | 2.04 | 19.92 | 19.92 | 19.92 | 30.51 | 16.59 | 15.63 | |
Foreign Promoters | % | 33.40 | 33.40 | 15.52 | 15.52 | 15.52 | 0.00 | 12.92 | 12.18 | |
Total Promoters | % | 35.44 | 35.44 | 35.44 | 35.44 | 35.44 | 30.51 | 29.51 | 27.81 | |
Mutual Funds | % | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Institution | % | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
Bodies Corporate | % | 1.21 | 1.23 | 1.02 | 1.34 | 1.02 | 0.40 | 0.32 | 0.44 | |
Individuals | % | 55.04 | 55.01 | 41.65 | 41.35 | 41.67 | 37.50 | 37.29 | 35.43 | |
NRIs/OCBs | % | 8.21 | 8.22 | 8.23 | 8.22 | 8.23 | 7.07 | 7.06 | 6.64 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.06 | 0.06 | 13.62 | 13.61 | 13.60 | 24.52 | 25.79 | 29.65 | |
Total Non-Institution | % | 64.52 | 64.52 | 64.52 | 64.52 | 64.52 | 69.49 | 70.46 | 72.16 | |
Total Public | % | 65.00 | 65.00 | 65.00 | 65.00 | 65.00 | 70.00 | 70.00 | 72.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.